Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.39 -0.05 (-10.87%)
At close: Aug 21, 2026 · 4:00 PM EDT

Senti Biosciences Holdings (SNTI) Invested Capital (2021 - 2024)

Senti Biosciences Holdings (SNTI) posted quarterly Invested Capital of $20000.0 for Q3 2024, little changed quarter-over-quarter from $20000.0 in Q2 2024.

Senti Biosciences Holdings (SNTI) Invested Capital (2021 - 2024) Analysis & Trends

Senti Biosciences Holdings' Invested Capital history runs 2 years deep, the most recent figure standing at $20000.0 for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 190.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.45 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 380.00 Mn
10 Senti Biosciences Holdings 12.06 Mn 12.06 Mn - 3.99 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 20,000.00
Jun 30, 2024 20,000.00
Mar 31, 2021 11,650.00